(Q33321671)

English

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

0 references

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

Stefano Del Prato

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

D Bruttomesso

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

D Crazzolara

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Maran

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

S Costa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Dal Pos

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Girelli

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

G Lepore

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

M Aragona

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

E Iori

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

U Valentini

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Tiengo

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Buhr

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

R Trevisan

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A Baritussio

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 March 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Diabetic Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

326-332

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Insulin pump therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Postprandial hyperglycemia and diabetes complications: is it time to treat?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Evaluation of a new measure of blood glucose variability in diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Crossover trials, degrees of freedom, the carryover problem and its dual

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

The pathobiology of diabetic complications: a unifying mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02365.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2007.02365.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18307459%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33321671&oldid=1634161934"